The moderna team is exploring how modified mRNA will create a new class of drugs native™ protein therapeutics.
Moderna is pioneering messenger RNA Therapeutics™, an entirely new treatment modality that enables the body to produce therapeutic proteins in vivo. Moderna is using this approach to develop first-ever treatments for a wide range of diseased that cannot be addressed today using existing technologies, and to drastically reduce the time and expense associated with creating therapeutic proteins using recombinant technologies. The company has demonstrated proof-of-concept using messenger RNA Therapeutics™ for a variety of indications and is moving multiple programs into the clinic. Visit www.modernatx.com to learn more.